Evidence map›Paper›PMID 22066590›Full record

ArticleBiomacromolecules2012

Imaging of homeostatic, neoplastic, and injured tissues by HA-based probes.

Mandana Veiseh, Daniel Breadner, Jenny Ma, Natalia Akentieva, Rashmin C Savani, Rene Harrison, David Mikilus, Lisa Collis, Stefan Gustafson, Ting-Yim Lee and 4 more

Abstract read
In one paragraph

Article in Biomacromolecules, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Mandana VeisehDivision of Life Sciences, Lawrence Berkeley National Laboratories, Berkeley, California, USA.
Daniel Breadner
Jenny Ma
Natalia Akentieva
Rashmin C Savani
Rene Harrison
David Mikilus
Lisa Collis
Stefan Gustafson
Ting-Yim Lee
James Koropatnick
Leonard G Luyt
Mina J Bissell
Eva A Turley
Western University · CALawrence Berkeley National Laboratory · USUniversity of Toronto · CAHospital for Sick Children · CAPediatrics and Genetics · USUppsala University · SE

Funding

Systems-Based Predictions of Responses to Cancer TherapyU54CA112970 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI GRAY, JOE W. · 2004 to 2014
$27.1M
TRANS-NETWORK PROJECTSU54CA143836 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI LIPHARDT, JAN T. · 2009 to 2014
$15.1M
Role of Metalloproteinases in Mammary Gland RemodelingR01CA057621 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WERB, ZENA · 1993 to 2017
$9.0M
Myoepithelial cell differentiation defects in ductal carcinoma in situ (DCIS)U01CA143233 · NCI · DANA-FARBER CANCER INST · PI BISSELL, MINA, POLLARD, JEFFREY W. · 2009 to 2013
$2.5M
Bioengineering 3-D Models for Organ-Specific Cancer Therapy in Lung and BreastU54CA126552 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI BISSELL, MINA · 2006 to 2010
$2.2M
Definition of Microenvironment in Breast CancerR37CA064786 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI BISSELL, MINA · 2009 to 2013
$2.0M
Hyaluronan in Lung Vascular DevelopmentR01HL075930 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI SAVANI, RASHMIN C · 2003 to 2006
$1.6M
INFLAMMATORY MECHANISMS &SURFACTANT IN LUNG INJURYR01HL062472 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI SAVANI, RASHMIN C · 2000 to 2003
$1.3M
Multiplex profiling and targeting of breast tumorigenic progenitor cellsF32CA132491 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI VEISEH, MANDANA · 2008 to 2010
$160k
CIHR MOP82720NCI NIH HHS F32 CA132491NCI NIH HHS R01 CA057621NCI NIH HHS R01CA057621NCI NIH HHS R37 CA064786NCI NIH HHS R37CA064786NCI NIH HHS U01 CA143233NCI NIH HHS U01CA143233NCI NIH HHS U54 CA112970NCI NIH HHS U54CA112970NCI NIH HHS U54 CA126552NCI NIH HHS U54CA126552NCI NIH HHS U54 CA143836NCI NIH HHS U54CA143836NHLBI NIH HHS R01 HL062472NHLBI NIH HHS R01 HL075930PHS HHS FCA132491A
6 · The paper itself

Abstract

An increase in hyaluronan (HA) synthesis, cellular uptake, and metabolism occurs during the remodeling of tissue microenvironments following injury and during disease processes such as cancer. We hypothesized that multimodality HA-based probes selectively target and detectably accumulate at sites of high HA metabolism, thus providing a flexible imaging strategy for monitoring disease and repair processes. Kinetic analyses confirmed favorable available serum levels of the probe following intravenous (i.v.) or subcutaneous (s.c.) injection. Nuclear (technetium-HA, (99m)Tc-HA, and iodine-HA, (125)I-HA), optical (fluorescent Texas Red-HA, TR-HA), and magnetic resonance (gadolinium-HA, Gd-HA) probes imaged liver ((99m)Tc-HA), breast cancer cells/xenografts (TR-HA, Gd-HA), and vascular injury ((125)I-HA, TR-HA). Targeting of HA probes to these sites appeared to result from selective HA receptor-dependent localization. Our results suggest that HA-based probes, which do not require polysaccharide backbone modification to achieve favorable half-life and distribution, can detect elevated HA metabolism in homeostatic, injured, and diseased tissues.

Indexed as

Liver Neoplasms, ExperimentalMammary Neoplasms, ExperimentalMolecular ProbesVascular DiseasesAnimalsCell Line, TumorFemaleHumansHyaluronic AcidMagnetic Resonance ImagingMiceNeoplasm TransplantationRatsRats, NudeTomography, OpticalTransplantation, HeterologousHyaluronic AcidMolecular Probes

Identifiers

PMID22066590
PMCPMC3658319
OpenAlexW2059356612

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.